Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: cancer + test + treatment  Related to the article below (Last Update: 8/5/2008)


OverTheLimit.info
Age limit suggested for cancer test
The Australian, Australia -
MEN should stop getting routine blood tests to check for prostate cancer once they reach 75 because the potential harm of treatment outweighs the benefits, ...
Stop prostate exams at age 75, federal panel recommends Los Angeles Times
Will Older Men Give Up the PSA Test? New York Times
US Panel Questions Prostate Screening Washington Post
Forbes - Reuters India
all 554 news articles »

BBC News
Man sues after cancer test mix up
BBC News, UK - Aug 4, 2008
He said: "Understandably, he and his family are extremely upset by the news and in particular the delay in treatment which could have implications on his ...
Vitamin C jabs may combat cancer
New Scientist (subscription), UK -
Meanwhile, the Cancer Treatment Centers of America (CTCA) in Zion, Illinois, is testing the safety of intravenous vitamin C in late-stage cancer patients ...
Saladax Biomedical Enters Agreement With Karolinska University ...
MarketWatch -
As a result, physicians will be better able to manage their patients and make more confident decisions in colorectal cancer treatment. ...
Gene Test Leads To Targeted Cancer Treatment
cbs4denver.com, CO -
He's since gone through strong chemotherapy treatment as well as radiation and surgery. Chen is currently in complete remission from the cancer. ...

HealthNews
Identifying Cancer Cells Allows Tumor-Specific Treatment
HealthNews, CA -
A new test that can help determine the type of cancer cells has been cleared for marketing by the Food and Drug Administration. ...
German Association of Gynecology and Obstetrics Recommends HPV ...
MarketWatch -
Early detection allows early treatment, ideally before cancer develops. The digene HPV Test has been validated in global studies that included more than ...

BBC News
Cancer-test blunder for 70 men
WalesOnline, United Kingdom - Aug 1, 2008
It is feared that the men were either wrongly given the all-clear when they did have prostate cancer, or have undergone unnecessary treatment for a disease ...
Sufferers told 'all-clear' in cancer scandal Melbourne Herald Sun
Consultant suspended after 17 cancer patients are given false all ... Mirror.co.uk
Patients misdiagnosed at Hereford County Hospital Hereford Times
Hospital Healthcare Europe - Daily Mail
all 37 news articles »
How MRI Scans Find Breast Cancers Like Christina Applegate's
U.S. News & World Report, DC -
For this reason, the test is recommended only for those at increased risk of breast cancer. (Breast cancer is very uncommon in those under 50, ...
Exposure To Agent Orange Linked To Prostate Cancer In Vietnam Veterans
Science Daily (press release) -
The research is also the first to utilize a large population of men in their 60s and the prostate-specific antigen (PSA) test to screen for the disease. ...
Source: Google News

Factors Associated with PTSD Symptoms Following Treatment for Breast Cancer: Test of the Andersen … -
MA Andrykowski, MJ Cordova - Journal of Traumatic Stress, 1998 - Springer
... Factors Associated with PTSD Symptoms Following Treatment for Breast Cancer: Test
of the Andersen Model Michael A. Andrykowski 1 -' and Mathew J. Cordova 1 ...

Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of- … -
MJ Hjermstad, SD Fossa, K Bjordal, S Kaasa - Journal of Clinical Oncology, 1995 - jcojournal.org
... ARTICLES. Test/retest study of the European Organization for Research and
Treatment of Cancer Core Quality-of-Life Questionnaire. ...

… Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer -
JL Lefebvre, D Chevalier, B Luboinski, A … - jnci, 1996 - jnci.oxfordjournals.org
... Organization for Research and Treatment of Cancer (EORTC) starting in ... The trial was
designed to test the equivalence of the two treatment arms; ie ...

… alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial -
JY Douillard, D Cunningham, AD Roth, M Navarro, RD … - The Lancet, 2000 - Elsevier
... dose-escalation studies were done to test combined irinotecan ... regimens were selected
for first-line treatment of advanced colorectal cancer, based on ...

… as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer -
CL Vogel, MA Cobleigh, D Tripathy, JC Gutheil, LN … - Journal of Clinical Oncology, 2002 - jcojournal.org
... chemotherapy for their metastatic breast cancer in this ... lack of pulmonary function
testing or abnormal ... 57%) received previous hormonal treatment, 42 patients ...

Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer -
T Andre, C Boni, L Mounedji-Boudiaf, M Navarro, J … - The New England Journal of Medicine, 2004 - nejm.org
... 23 In our study, this test showed no significant ... between the stage of disease and
the treatment, indicating that ... both stage II and stage III colorectal cancer. ...
-

… Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non-Small-Cell Lung Cancer: The TAX 326 … -
F Fossella, JR Pereira, J von Pawel, A Pluzanska, … - Journal of Clinical Oncology, 2003 - jco.ascopubs.org
... QoL assessments included the validated, disease-specific, Lung Cancer Symptom Scale ...
was greater than 0.85, which means that the test treatment preserves at ...

… examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed … -
G Lu-Yao? - BMJ, 2002 - pubmedcentral.nih.gov
... Screening for prostate cancer with the prostate specific antigen test is widely ... whether
early detection and aggressive treatment reduce mortality from ...

Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model -
W Arap, R Pasqualini, E Ruoslahti - Science, 1998 - sciencemag.org
... improve the therapeutic index of cancer chemotherapeutics, we ... Rank test, P < 0.0001;
Wilcoxon test, P = 0.0007 ... then observed, without further treatment, for an ...

Fatigue and Quality of Life Outcomes of Exercise During Cancer Treatment -
V Mock, M Pickett, ME Ropka, EM Lin, KJ Stewart, … - Cancer, 2001 - Blackwell Synergy
... prescription was individualized for subjects based on age, level of physical fitness
as determined by the baseline walk test, and type of cancer treatment. ...

Source: Google Scholar

Genetic test guides cancer treatment, company says

Last Updated: 2007-12-13 14:01:49 -0400 (Reuters Health)

LOS ANGELES - Genomic Health Inc said on Thursday its genetic test can help predict when chemotherapy is likely to benefit women with breast cancer that has spread to the lymph nodes.

Genomic Health's Oncotype DX test measures the activity of several cancer-related genes to generate a "recurrence score" that can help assess a patient's risk for recurrence and predict how well the patient will respond to chemotherapy.

Researchers ran the test on hundreds of tissue samples from a breast cancer trial that began in the late 1980s. The study also used survival data from the prior trial.

Results showed that the test could be an aid in deciding when to give chemotherapy to tamoxifen-treated, post-menopausal women with so-called estrogen receptor positive breast cancer that has invaded the lymph notes, researchers said in a presentation at the San Antonio Breast Cancer Symposium.

Government insurance plans, as well as many private insurers, already cover the test for early-stage breast cancer patients.

Copyright © 2007 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

 

Drug to treat genetic disorder PKU approved in US

Last Updated: 2007-12-13 14:04:49 -0400 (Reuters Health)

LOS ANGELES - BioMarin Pharmaceutical Inc won U.S. approval for the first prescription drug to treat a serious genetic disorder called phenylketonuria (PKU), the U.S. Food and Drug Administration said on Thursday.

The drug, called Kuvan, was developed with Merck Serono, a division of Merck KGaA . News of the approval sent BioMarin shares up 6 percent to their highest level since early 2000. People with PKU are not able to break down phenylalanine, an amino acid found in foods, which can build up in the blood. High levels of phenylalanine are toxic to the brain and can lead to mental retardation, behavioral abnormalities, seizures, an inability to focus and organize information, and other neurological complications. FDA said the safety and efficacy of Kuvan was demonstrated in four short-term clinical studies with 579 patients with the disease. Regulators said Kuvan works by increasing phenylalanine hydroxylase enzyme activity, which helps break down phenylalanine and results in lower levels of phenylalanine in the blood. Shares in BioMarin were up $1.67 to $29.85 in afternoon Nasdaq trade; they traded as high as $30.49 earlier. Stock in the Novato, California-based company is up around 80 percent so far this year.

Copyright © 2007 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

US to do health tests on Katrina victims' trailers

Last Updated: 2007-12-13 14:11:49 -0400 (Reuters Health)

WASHINGTON - Federal health experts will begin testing for formaldehyde in trailers provided to people displaced by Hurricane Katrina after complaints of health problems, U.S. officials said on Thursday.

The U.S. Centers for Disease Control and Prevention will conduct indoor air-quality tests for formaldehyde starting Dec. 21 on 500 of the roughly 46,000 government-provided trailers and mobile homes in Mississippi and Louisiana, officials said. Tens of thousands of people lost homes in the hurricane's onslaught in 2005.

Some trailer residents have attributed health problems to exposure to formaldehyde.

The CDC is doing the job at the request of the U.S. Federal Emergency Management Agency, whose response to the disaster has been criticized as slow and ineffective. Tests had been due to begin last month, but officials postponed them.

Jim Stark, director of FEMA's office in New Orleans coordinating recovery efforts, said about 3,700 people already have asked to move from the trailers due to formaldehyde fears, and have been offered housing alternatives.

"In most cases, this will mean a trip to a motel or a hotel until appropriate rental units can be found," Stark said.

FEMA will provide immediate alternative housing to any trailer residents with such health concerns, Stark said.

Formaldehyde is a chemical used widely in the manufacture of building materials. It also is used in embalming fluid. It can irritate the skin, eyes, nose and throat, and high levels of exposure may cause some types of cancers, the CDC said.

FEMA bought the trailers to provide temporary housing for displaced Gulf Coast residents. Stark estimated about 90,000 people are living in the trailers, mostly in Louisiana and Mississippi with smaller numbers in Alabama and Texas.

The CDC said the testing will take about five weeks. Dr. Henry Falk, head of the CDC's Coordinating Center for Environmental Health and Injury Prevention, said officials hope disclose the results by mid-February.

During the testing, officials also will look for other "obvious problems such as heavy mold," Falk said.

"It is important not to be in an environment with high formaldehyde exposure for a very long term. We really want to try to head off the concern about those long-term effects," Falk said at a news conference in New Orleans, which was carried on a telephone link.

"The tests may all be high, they may all be low, they may vary by particular type of trailer," Falk added. "I think, depending on the findings, that will help us in anticipating what we might need to do in the future."

There are no federal guidelines or scientific standards on formaldehyde levels in such trailers, officials said.

Copyright © 2007 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
Continue News With: News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.